Doctor of Science Vicente Vérez Bencomo, general director of the Finlay Vaccine Institute (IFV), announced that in April they should produce the first million vaccines against COVID-19 from that center, which will allow expanding their application and demonstrating with more evidence their efficacy.

The Center for Genetic Engineering and Biotechnology (CIGB) expects to advance in March to Phase III of the clinical trials of the Abdala vaccine candidate (CIGB-66), after more than 300 individuals participated in the second stage of its short vaccination scheme.

Cancer is the second leading cause of death in the Americas, where in 2020 four million new cases were diagnosed and about 1.4 million people died, said Dr. Carissa F. Etienne, Director of the Pan American Health Organization (PAHO).

Cuban President Miguel Díaz-Canel Bermúdez highlighted the recognition of the Prime Minister of Barbados, Mia Mottey, to the medical assistance provided by Cuban professionals.

More than 1,700 people in the province of Matanzas have already received doses of Nasalferon, an immunoprotective product derived from recombinant human Interferon Alpha 2b, as part of the study to evaluate its effectiveness against the SARS CoV-2 coronavirus.

Cuban President Miguel Díaz-Canel Bermúdez expressed today Cuba's gratitude to the head of the South African state Cyril Ramaphosa’s support for the Henry Reeve Medical Contingent Nobel Peace Prize nomination.

When the COVID-19 is raging and refuses to be banished from Cuba and the world, in recent months the increase of the contagion in pediatric patients on the island has been worrying, something that alerts the medical community and activates efforts, as can be seen today in the province of Guantánamo, the province with the highest incidence rate of the pandemic in the country.

Cuba joins the global community in commemorating World Cancer Day, a disease that, according to the Pan American Health Organization, is the second leading cause of death in the Americas.

The fact that more beds are being prepared for the prevention and control of HIV/AIDS-19 is frightening news, but it also means that the conditions to solve this third outbreak of the pandemic are growing in effectiveness.

The new facilities of the Center for Neurosciences of Cuba (CNEURO), close to the completion of its investment process, will have a large production capacity for the manufacture of swabs used in PCR sampling.

Cuba studied 18,004 samples for COVID 19, resulting in 1,044 positive ones. The country accumulates 1, 922,930 samples taken and 28,636 positive.

One of the four Cuban COVID 19 candidate vaccines has just begun phase 2 of clinical trials in Santiago de Cuba province.

Cuba reported in January 15,536 positive cases of SARS-CoV-2 and 70 deaths from the disease, the highest figures since the outbreak of the epidemic in the country in March last year.

Cuba studied 18,403 samples for COVID-19, resulting in 906 positive ones. The country accumulates 1,904,926 samples taken and 27,592 positive.